Anti-HIV therapy in 1996... AIDS: a primary care handbook.

Autor: Davey RT Jr., Goldschmidt RH, Sande MA

Publikováno v: Patient Care (Print); 5/15/1996, Vol. 30 Issue 9, p55-68, 10p

Safety and immunogenicity of a delayed booster dose of the rVSVΔG-ZEBOV-GP vaccine for prevention of Ebola virus disease: a multicentre, open-label, phase 2 randomised controlled trial.

Autor: Davey RT Jr; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. Electronic address: rdavey@niaid.nih.gov., Collins GL; Division of Biostatistics, University of Minnesota, Minneapolis, MN, USA., Rouphael N; Hope Clinic of Emory Vaccine Center, Emory University, Atlanta, GA, USA., Poliquin G; Public Health Agency of Canada, Children's Hospital Research Institute, Winnipeg, MB, Canada., McConnell R; Critical Care Medicine Department, Clinical Research Center, National Institutes of Health, Bethesda, MD, USA., Grubbs G; Division of Viral Products, Center for Biologics Evaluation and Research, US Food & Drug Administration, Silver Spring, MD, USA., Moir SL; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Langley JM; Canadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health Authority, Dalhousie University, Halifax, NS, Canada., Teitelbaum M; Clinical Monitoring Research Program, Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Hewlett AL; Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, NE, USA., McLellan SLF; Division of Infectious Diseases, Dept of Medicine, School of Medicine, University of Texas Medical Branch, Galveston, TX, USA., Bhadelia N; Boston University Center for Emerging Infectious Diseases Policy and Research, Boston University, Boston, MA, USA., Raabe VN; New York University Grossman School of Medicine, New York, NY, USA., Mulligan MJ; New York University Grossman School of Medicine, New York, NY, USA., Maljkovic Berry I; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, USA., Dighero-Kemp B; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, USA., Kurtz JR; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, USA., Hensley LE; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, USA., Dozier NCE; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, USA., Marron LCB; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, USA., DuChene A; Division of Biostatistics, University of Minnesota, Minneapolis, MN, USA., Kuhn JH; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD, USA., Brown SK; Applied and Developmental Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Khurana S; Division of Viral Products, Center for Biologics Evaluation and Research, US Food & Drug Administration, Silver Spring, MD, USA., Lane HC; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Neaton JD; Division of Biostatistics, University of Minnesota, Minneapolis, MN, USA.

Publikováno v: The Lancet. Microbe [Lancet Microbe] 2024 Nov; Vol. 5 (11), pp. 100923. Date of Electronic Publication: 2024 Oct 04.

Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza.

Autor: Vanderven HA; Biomedicine, College of Public Health, Medical and Veterinary Sciences, and.; Australian Institute of Tropical Health and Medicine, James Cook University, Douglas, Queensland, Australia.; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, Australia., Wentworth DN; Divison of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA., Han WM; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.., Peck H; WHO Collaborating Centre for Reference and Research on Influenza at the Peter Doherty Institute of Infection and Immunity, Melbourne, Victoria, Australia., Barr IG; WHO Collaborating Centre for Reference and Research on Influenza at the Peter Doherty Institute of Infection and Immunity, Melbourne, Victoria, Australia., Davey RT Jr; National Institute of Allergy and Infectious Disease (NIAID), Bethesda, Maryland, USA., Beigel JH; National Institute of Allergy and Infectious Disease (NIAID), Bethesda, Maryland, USA., Dwyer DE; New South Wales Health Pathology-Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, Australia., Jain MK; UT Southwestern Medical Center, Dallas, Texas, USA., Angus B; Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom., Brandt CT; Department of Infectious Diseases, Zealand University Hospital Roskilde, Denmark., Mykietiuk A; Instituto Médico Platense, Buenos Aires, Argentina., Law MG; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.., Neaton JD; Divison of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA., Kent SJ; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, Australia.; Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Health, Central Clinical School, Monash University, Carlton, Victoria, Australia.

Publikováno v: JCI insight [JCI Insight] 2023 Jul 24; Vol. 8 (14). Date of Electronic Publication: 2023 Jul 24.

Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial.

Autor: Potter GE; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland (G.E.P.)., Bonnett T; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland (T.B., K.R.)., Rubenstein K; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland (T.B., K.R.)., Lindholm DA; Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, and Brooke Army Medical Center, Joint Base San Antonio-Fort Sam Houston, Texas (D.A.L.)., Rapaka RR; University of Maryland Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland (R.R.R.)., Doernberg SB; Department of Medicine, Division of Infectious Diseases, University of California, San Francisco, San Francisco, California (S.B.D.)., Lye DC; National Centre for Infectious Diseases, Tan Tock Seng Hospital, Yong Loo Lin School of Medicine, and Lee Kong Chian School of Medicine, Singapore (D.C.L.)., Mularski RA; Department of Pulmonary and Critical Care Medicine, Northwest Permanente PC, and Kaiser Permanente Northwest Center for Health Research, Portland, Oregon (R.A.M.)., Hynes NA; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland (N.A.H.)., Kline S; Department of Medicine, Division of Infectious Diseases and International Medicine, University of Minnesota Medical School, Minneapolis, Minnesota (S.K.)., Paules CI; Division of Infectious Diseases, Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania (C.I.P.)., Wolfe CR; Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina (C.R.W.)., Frank MG; Department of Medicine, Denver Health Hospital Authority, Denver, Colorado, and University of Colorado School of Medicine, Aurora, Colorado (M.G.F.)., Rouphael NG; Hope Clinic, Emory Vaccine Center, Infectious Diseases Division, Atlanta, Georgia (N.G.R.)., Deye GA; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (G.A.D., S.U.N., K.M.T.)., Sweeney DA; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of California San Diego, San Diego, California (D.A.S.)., Colombo RE; Madigan Army Medical Center, Tacoma, Washington, Infectious Diseases Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland (R.E.C.)., Davey RT Jr; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (R.T.D.)., Mehta AK; Division of Infectious Diseases, Emory University School of Medicine, and National Emerging Special Pathogens Training and Education Center, Atlanta, Georgia (A.K.M.)., Whitaker JA; Departments of Molecular Virology and Microbiology and Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, Texas (J.A.W.)., Castro JG; Division of Infectious Diseases, University of Miami, Miami, Florida (J.G.C.)., Amin AN; Department of Medicine, University of California, Irvine, Irvine, California (A.N.A.)., Colombo CJ; Madigan Army Medical Center, Tacoma, Washington, and Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland (C.J.C.)., Levine CB; Department of Internal Medicine, Division of Infectious Disease, University of Texas Medical Branch, Galveston, Texas (C.B.L.)., Jain MK; Department of Internal Medicine, Division of Infectious Disease and Geographic Medicine, UT Southwestern Medical Center, and Parkland Health & Hospital System, Dallas, Texas (M.K.J.)., Maves RC; Wake Forest University School of Medicine, Winston-Salem, North Carolina, and Infectious Diseases Clinical Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland (R.C.M.)., Marconi VC; Emory University School of Medicine, Rollins School of Public Health, and Atlanta Veterans Affairs Medical Center, Atlanta, Georgia (V.C.M.)., Grossberg R; Department of Medicine, Division of Infectious Diseases, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York (R.G.)., Hozayen S; Department of Medicine, Division of Hospital Medicine, University of Minnesota, Minneapolis, Minnesota (S.H.)., Burgess TH; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland (T.H.B.)., Atmar RL; Department of Medicine, Baylor College of Medicine, Houston, Texas (R.L.A.)., Ganesan A; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and Walter Reed National Military Medical Center, Bethesda, Maryland (A.G.)., Gomez CA; Department of Internal Medicine, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska (C.A.G.)., Benson CA; Division of Infectious Diseases and Global Public Health, University of California San Diego, San Diego, California (C.A.B.)., Lopez de Castilla D; Division of Infectious Diseases, Evergreen Health Medical Center, Kirkland, Washington (D.L.)., Ahuja N; Department of Internal Medicine, Stanford University Medical Center, Palo Alto, California (N.A.)., George SL; Saint Louis University and St. Louis VA Medical Center, Saint Louis, Missouri (S.L.G.)., Nayak SU; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (G.A.D., S.U.N., K.M.T.)., Cohen SH; Division of Infectious Diseases, University of California, Davis, Sacramento, California (S.H.C.)., Lalani T; Naval Medical Center Portsmouth, Portsmouth, Virginia, Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, Maryland (T.L.)., Short WR; Department of Medicine, Division of Infectious Diseases, University of Pennsylvania, Philadelphia, Pennsylvania (W.R.S.)., Erdmann N; Division of Infectious Diseases, Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama (N.E.)., Tomashek KM; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (G.A.D., S.U.N., K.M.T.)., Tebas P; Division of Infectious Diseases/Clinical Trials Unit, University of Pennsylvania, Philadelphia, Pennsylvania (P.T.).

Publikováno v: Annals of internal medicine [Ann Intern Med] 2022 Dec; Vol. 175 (12), pp. 1716-1727. Date of Electronic Publication: 2022 Nov 29.

High-throughput, single-copy sequencing reveals SARS-CoV-2 spike variants coincident with mounting humoral immunity during acute COVID-19.

Autor: Ko SH; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Bayat Mokhtari E; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Mudvari P; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Stein S; Emerging Pathogens Section, Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, United States of America.; Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Stringham CD; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Wagner D; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Ramelli S; Emerging Pathogens Section, Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, United States of America., Ramos-Benitez MJ; Emerging Pathogens Section, Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, United States of America.; Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Strich JR; Emerging Pathogens Section, Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, United States of America., Davey RT Jr; Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Zhou T; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Misasi J; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Kwong PD; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Chertow DS; Emerging Pathogens Section, Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, United States of America.; Laboratory of Immunoregulation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Sullivan NJ; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Boritz EA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.

Publikováno v: PLoS pathogens [PLoS Pathog] 2021 Apr 08; Vol. 17 (4), pp. e1009431. Date of Electronic Publication: 2021 Apr 08 (Print Publication: 2021).